←
DEM BioPharma6 posts
DEM BioPharma avatar

DEM BioPharma

@DEMBioPharma

Pioneering the next-generation of macrophage immunotherapies

◷ Joined June 2022▧ 6 Photos and videos
DEM BioPharma avatar
DEM BioPharma@DEMBioPharma·27 Sep 2022

Following our successful launch with a $70M financing in June, we welcome Nenad Grmusa as CEO, Christophe Quéva, Ph.D., as CSO & Loise Francisco-Anderson, Ph.D., as SVP & Head of Biology as we continue to pioneer the next generation of immunotherapeutics: bwnews.pr/3RgHz7O

Post attachment
DEM BioPharma avatar
DEM BioPharma@DEMBioPharma·24 Jun 2022

#ICYMI We launched with a $70M financing! We're focused on accessing the untapped opportunity around macrophage biology and innate immune system pathways to discover potent DEM and EM signals on cancers and expand the therapeutic potential of the field. bwnews.pr/3xKQlDy

Post attachment
DEM BioPharma avatar
DEM BioPharma@DEMBioPharma·23 Jun 2022

We're excited to announce our launch with a $70M financing! Leveraging a proprietary CRISPR screening platform and macrophage biology, we are systematically discovering and targeting novel “don’t eat me” (DEM) and “eat me” (EM) signals to eliminate cancer. bwnews.pr/3xKQlDy

Post attachment